Alpna Seth - May 1, 2023 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Stock symbol
KROS
Transactions as of
May 1, 2023
Transactions value $
$0
Form type
3
Date filed
5/3/2023, 04:44 PM
Previous filing
Oct 31, 2022
Next filing
Jun 2, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney